INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 48m ago
HOUSE PTR7m ago
SEC 13F7m ago
ROBINHOOD CHAIN7m ago
Public company

ARTVArtiva Biotherapeutics, Inc.

CIK 0001817241

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells2 / 0
Max Insider Score59
Connections3with evidence

ARTV · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
59
GC
GC Corp.10% Owner
ARTVArtiva Biotherapeutics, Inc.
Open-market purchase
BUY$12.50M
1.09M sh
May 11, 2026May 28, 2026
traded May 11, 2026
+17dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Insider ofevidence
    GC Corp.10% Owner · May 28, 2026
  • ← Insider ofevidence
    GC Cell Corp10% Owner · May 28, 2026
56
GC
GC Corp.10% Owner
ARTVArtiva Biotherapeutics, Inc.
Open-market purchase
BUY
$4.00M
347.2K sh
May 11, 2026
May 28, 2026
traded May 11, 2026
+17d
SEC FORM 4

Evidence